Proteomics International Laboratories Ltd. announced the appointment of Mr. Roger Moore as a Non-Executive Director of the company. The appointment brings key industry and sector experience to the Board as the company seeks to commercialise its lead diagnostics product, PromarkerD, and expand its analytical services in Asia. Roger Moore has 40 years experience in the international pharmaceutical industry, including almost 30 years as President of Novo Nordisk Japan. Mr. Moore established Novo's organisation in Japan as the first employee in 1977, and worked for the company until his retirement as Chairman at the end of 2007.